NCT06708299

CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2025-04-07Est. Completion: 2026-09-21

Enrollment target: 110 participants

Locations

Mayo Clionic Arizona, Phoenix, Arizona, United States
UCI Health, Irvine, California, United States
Altman Clinical and Translational Research Institute, La Jolla, California, United States
Cedars-Sinai Medical Center, Los Angeles, California, United States
Pacific Heart Institute at Cedars-Sinai, Santa Monica, California, United States
Mayo Clinic Florida, Jacksonville, Florida, United States
Northwestern University, Chicago, Illinois, United States
Johns Hopkins University, Baltimore, Maryland, United States
MedStar Health Institute, Columbia, Maryland, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Minneapolis Heart Institute, Minneapolis, Minnesota, United States
Mayo Clinic, Rochester, Minnesota, United States
NYU Langone Health, New York, New York, United States
Columbia University - New York Presbyterian, New York, New York, United States
Lenox Hill Hospital, New York, New York, United States
Cleveland Clinic, Cleveland, Ohio, United States

Pericarditis

А multicenter, non-interventional real world clinical registry of patients with recurrent pericarditis. The main goal o…

Moscow, RussiaEst. completion Jul 30, 2027

Ventricular Arrhythmia

Background: Ventricular arrhythmia is an abnormal pulse rhythm that starts in the lower part of the heart (ventricles).…

Atlanta, United StatesCompleted Dec 1, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.